Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent progress in application of nanovaccines for enhancing mucosal immune responses
Guangsheng Du, Ming Qin, Xun Sun
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 6, pp. 2334-2345
Open Access | Times Cited: 24

Showing 24 citing articles:

The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 22
Nanocarriers of antigen proteins for vaccine delivery
Luíse Lopes Chaves, Douglas Dourado, Ioana-Bianca Prunache, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124162-124162
Closed Access | Times Cited: 8
In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases
Yuan Li, Fan Tong, Yufan Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4102-4117
Open Access | Times Cited: 7
Next-generation aluminum adjuvants: Immunomodulatory layered double hydroxides NanoAlum reengineered from first-line drugs
Zhenwei Su, Hamza Boucetta, Jiahui Shao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4665-4682
Open Access | Times Cited: 6
Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses
Dung T. Huynh, Emanuele Nolfi, Lobna Medfai, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Nano-adjuvant based on lipo-imiquimod self-assembly for enhanced foot-and-mouth disease virus vaccine immune responses via intradermal immunization
Wenzhu Yin, Zeyu Xu, Fang Ma, et al.
Materials Today Bio (2025) Vol. 31, pp. 101567-101567
Open Access
Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy
Wanqiong Li, Xin Yang, Mengfan Wang, et al.
Nano Letters (2025)
Closed Access
Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and function
Yuhong Jiang, Shanshan Qi, Canquan Mao
Acta Pharmaceutica Sinica B (2025)
Open Access
Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes
Mohammad A. Obeid, Marta Ruano-Aldea, Reinaldo Acevedo, et al.
Therapeutic Delivery (2025), pp. 1-14
Closed Access
Advances in mucosal vaccines: Design strategies for antigens, adjuvants, and delivery systems
Jiaxin Guo, Yongyi Xie, Muhammad Waqqas Hasan, et al.
Chinese Chemical Letters (2025), pp. 111213-111213
Closed Access
Tough and waterproof microneedles overcome mucosal immunotolerance by modulating antigen release patterns
Penghui He, Chun‐Ting He, Rong Guo, et al.
Journal of Controlled Release (2025) Vol. 382, pp. 113740-113740
Closed Access
Immune Modulation with Oral DNA/RNA Nanoparticles
Ulpan Kart, Aigul Raimbekova, Sergey Yegorov, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 609-609
Open Access
Advancements in the use of cancer nanovaccines: Comprehensive insights with focus on lung and colon cancer
Qian Li, Jingjuan Shi, Caixia Pei, et al.
Nanotechnology Reviews (2025) Vol. 14, Iss. 1
Open Access
Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming
Shixin Duan, Xinyi Lou, Shiyi Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4785-4800
Open Access | Times Cited: 9
Fabrication of chitosan-based emulsion as an adjuvant to enhance nasal mucosal immune responses
Donghui Li, Wenbo Li, Sheng Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132913-132913
Closed Access | Times Cited: 3
A Narrative Review on the Promising Potential of Graphene in Vaccine Design: Evaluating the Benefits and Drawbacks of Carbon Nanoplates in Nanovaccine Production
Hadi Zare‐Zardini, Elham Saberian, Andrej Jenča, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 660-660
Open Access | Times Cited: 1
Respiratory delivered vaccines: Current status and perspectives in rational formulation design
Lan Wu, Wenwen Xu, Huiyang Jiang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5132-5160
Open Access | Times Cited: 1
Nanospheres as the delivery vehicle: novel application of Toxoplasma gondii ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis
WeiYu Qi, YouLi Yu, Chenchen Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Mannose targeting of poly(lactic-co-glycolic acid): a promising approach for improving sublingual allergen-specific immunotherapy
Navideh Haghnavaz, Mohammad Ali Rezaee, Safoora Pordel, et al.
Immunopharmacology and Immunotoxicology (2024) Vol. 46, Iss. 6, pp. 815-828
Closed Access
NK cell membrane/MnO2 hybrid nanoparticle-adjuvanted intranasal vaccines synergistically boost protective immunity against H1N1 influenza infection
Hanghang Cheng, Lingli Shen, Xiaoning Liu, et al.
Chemical Engineering Journal (2024), pp. 157381-157381
Closed Access
Diagnosis and Treatment of COVID-19 Using Nanomedicinal Approach
Kavita Sharma, Sakshi Kamboj, Vaishali, et al.
(2024), pp. 1115-1141
Closed Access
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus
Myriam Lamrayah, Fanny Charriaud, Manon Desmares, et al.
Antiviral Research (2022) Vol. 209, pp. 105483-105483
Open Access | Times Cited: 2
Editorial of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection
Wei He, Alejandro Sosnik, Chenjie Xu
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2296-2297
Open Access
Page 1

Scroll to top